HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Stasis of bile duct — Clinical Guidelines

Overview

Stasis dermatitis and related conditions arise from impaired venous drainage, often leading to chronic leg ulcers and skin complications such as dermatitis and infections. 1 2 3 4 5

Diagnosis

Presence of chronic leg edema and skin changes indicative of venous insufficiency.

Skin biopsy may identify specific pathogens (e.g., Fusarium species) in cases of secondary infections 1.

Elevated plasma homocysteine (Hcy) levels can be a marker, with levels typically above 8.1 μmol/L in affected patients 3.

Patch testing for contact allergens in patients with leg ulcers to identify irritants or allergens 5.

Management

First-line treatments: Compression therapy to improve venous return.

Topical corticosteroids for acute inflammation management.

Topical tacrolimus (0.1% ointment) as an alternative or adjunct, showing potential efficacy in healing 4.

Address underlying causes such as medication side effects (e.g., consider discontinuing amlodipine if associated with stasis dermatitis) 2.

Manage hyperhomocysteinemia with appropriate supplementation or dietary interventions if elevated Hcy levels are identified 3.

Special Populations

Elderly: Topical tacrolimus may be effective, though further studies are needed 4.

Comorbidities: Consider impact of systemic conditions (e.g., diabetes) on healing and infection risk 3.

Key Recommendations

Implement compression therapy to manage venous insufficiency and prevent progression 2 3. (Evidence: Strong)

Evaluate and consider discontinuing amlodipine in patients with suspected drug-induced stasis dermatitis 2. (Evidence: Moderate)

Monitor and manage hyperhomocysteinemia levels in patients with stasis dermatitis and ulcer, potentially through supplementation 3. (Evidence: Moderate)

Explore the use of topical tacrolimus for refractory cases, acknowledging the need for further clinical trials 4. (Evidence: Weak)

References

1 Mansur AT, Artunkal S, Ener B. Fusarium oxysporum infection of stasis ulcer: eradication with measures aimed to improve stasis. Mycoses 2011. link 2 Gosnell AL, Nedorost ST. Stasis dermatitis as a complication of amlodipine therapy. Journal of drugs in dermatology : JDD 2009. link 3 Durmazlar SP, Akgul A, Eskioglu F. Hyperhomocysteinemia in patients with stasis dermatitis and ulcer: a novel finding with important therapeutic implications. The Journal of dermatological treatment 2009. link 4 Dissemond J, Knab J, Lehnen M, Franckson T, Goos M. Successful treatment of stasis dermatitis with topical tacrolimus. VASA. Zeitschrift fur Gefasskrankheiten 2004. link 5 Angelini G, Rantuccio F, Meneghini CL. Contact dermatitis in patients with leg ulcers. Contact dermatitis 1975. link

Stasis of bile duct